Haleon plc
HLN.L
Get informed when a big investor buys or sells
+ FollowMarket Cap$38.75B
Close$
Share Statistics
| Market cap | $38.75 Billion |
|---|---|
| Enterprise Value | $46.13 Billion |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | 11.32% |
|---|---|
| Return on Assets | 5.69% |
| Return on Invested Capital | 11.06% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 3.36 |
| Enterprise Value to EBIT | 15.93 |
| Enterprise Value to Net Income | 25 |
| Total Debt to Enterprise | 0.18 |
| Debt to Equity | 0.5 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 30, 2026
EPS Estimate
$0.09
Average shareholder expectationRevenue Estimate
$5.59 B
Average shareholder expectationNext Earnings Call
Expected Date
March 4, 2027
EPS Estimate
$0.11
Average shareholder expectationRevenue Estimate
$5.79 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Haleon plc
24,561 employees
CEO: Brian James McNamara Haleon plc operates as a global consumer healthcare enterprise, actively involved in the research, development, production, and distribution of a diverse range of products. Its business activities cover extensive regions, including North...